Pfizer ups COVID-19 vaccine revenue estimates

By Rachel Arthur

Pfizer has upped its 2021 sales forecast for its mRNA COVID-19 vaccine to $26bn: as well as reporting strong Q1 results for the business overall this morning.


GSK to help manufacture Novavax COVID-19 vaccine

By Rachel Arthur

GSK will help manufacture up to 60 million doses of Novavax’s COVID-19 vaccine from its facility at Barnard Castle in the UK, with doses to be distributed in the country.

© GettyImages/solarseven

Raft of Indian pharma firms set to produce Sputnik V vaccine

By Jane Byrne

The RDIF, Russia’s sovereign wealth fund, and India based, Virchow Biotech Private Limited, have today announced a partnership to produce and supply a minimum of 200 million doses of the Russia developed Sputnik V vaccine against COVID-19.


France ramps up COVID-19 vaccine production

By Rachel Arthur

Three COVID-19 vaccine manufacturing sites are set to start production in France in the coming weeks: while the French government is seeking to boost further production with a €300m ($363m) initiative announced on Monday.

Follow us


View more